Loading organizations...
§ Private Profile · Rehovot, HaMerkaz, Israel
Medical device developer creating hybrid laser catheter technology for physicians performing atherectomy in peripheral arterial disease.
Eximo Medical is a Rehovot, Israel-based medical device company that develops proprietary hybrid catheter technology utilizing a 355nm wavelength laser for atherectomy procedures to treat peripheral arterial disease. The company's core B-Laser system combines laser and blunt blade components to reduce vessel perforation risks during transluminal applications, targeting a total addressable market of over 200,000 annual cases in the United States. Prior to its exit, the venture-backed developer secured $1.6 million in Series A funding from a syndicate of institutional investors that included Accelmed, Arkin Holdings, and Peregrine Ventures. In 2019, the business was acquired by medical technology manufacturer AngioDynamics for an initial base price of $46 million, alongside up to $20 million in additional milestone payments. Eximo Medical was originally founded in 2012 by Ilan Ben Oren, Dr. Yossi Muncher, and Yoel Zabar.
Eximo Medical has raised $1.6M across 1 funding round.
Eximo Medical has raised $1.6M in total across 1 funding round.
Eximo Medical has raised $1.6M across 1 funding round. Most recently, it raised $1.6M Series A in July 2015.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 29, 2015 | $1.6M Series A | Accelmed | Alfred Mann Institute AT The Technion, Technion Research And Development Foundation | Announced |
Eximo Medical has raised $1.6M in total across 1 funding round.
Eximo Medical's investors include Accelmed, Alfred Mann Institute at the Technion, Technion Research and Development Foundation.